Laura Clague - Chief Financial Officer at Travere Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
TVTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Laura Clague since 4/23/2024

Holdings reported by Laura Clague for Travere Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 35.7K $319K $8.96 May 11, 2022 Direct
Performance-based restricted stock units 8K $188K $23.53 Jan 31, 2022 Direct Common Stock
Employee stock option (right to buy) 39.4K Jan 31, 2022 Direct Common Stock

Transactions reported by Laura Clague for Travere Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.